scispace - formally typeset
S

Stefan Rothenburg

Researcher at University of California, Davis

Publications -  55
Citations -  2212

Stefan Rothenburg is an academic researcher from University of California, Davis. The author has contributed to research in topics: Gene & Virus. The author has an hindex of 22, co-authored 45 publications receiving 1752 citations. Previous affiliations of Stefan Rothenburg include Kansas State University & University of California, Berkeley.

Papers
More filters
Journal ArticleDOI

Poxviruses and the evolution of host range and virulence.

TL;DR: The biology of poxviruses is reviewed with a focus on host range, zoonotic infections, virulence, genomics and host range genes as well as the current knowledge about the function of poXv virus host range factors and how their interaction with the host innate immune system contributes to poxvirus host range and virulence.
Journal ArticleDOI

Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1.

TL;DR: ZBP1 was recently identified as a cytosolic pattern recognition receptor of double-stranded DNA, and thus, ZBP1 is proposed as a model for HCMV-mediated IRF3 activation that involves H CMV-associated DNA as the principal innate immune-activating pathogen-associated molecular pattern.
Journal ArticleDOI

A PKR-like eukaryotic initiation factor 2α kinase from zebrafish contains Z-DNA binding domains instead of dsRNA binding domains

TL;DR: This previously undescribed kinase, designated PKZ (protein kinase containing Z-DNA binding domains), is transcribed constitutively at low levels and is highly induced after injection of poly(inosinic)-poly(cytidylic) acid, which simulates viral infection.
Journal ArticleDOI

A polymorphic dinucleotide repeat in the rat nucleolin gene forms Z-DNA and inhibits promoter activity.

TL;DR: This finding suggests that differences in Z-DNA formation by polymorphic dinucleotide repeats may be one of the factors contributing to genetic variation.
Journal ArticleDOI

Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo

TL;DR: A proof of principle that opens up a new avenue for targeting leukocyte ecto‐enzymes in vivo and that can serve as a model also for developing new antidotes against ADP‐ribosylating toxins is formed.